
### [MONDO:0019241](http://purl.obolibrary.org/obo/MONDO_0019241)
**Label:** disorder of the gamma-glutamyl cycle

**Subclasses:** [MONDO:0009947](http://purl.obolibrary.org/obo/MONDO_0009947) (glutathione synthetase deficiency with 5-oxoprolinuria), [MONDO:0009284](http://purl.obolibrary.org/obo/MONDO_0009284) (glutathione synthetase deficiency without 5-oxoprolinuria), [MONDO:0009285](http://purl.obolibrary.org/obo/MONDO_0009285) (gamma-glutamyl transpeptidase deficiency), [MONDO:0017909](http://purl.obolibrary.org/obo/MONDO_0017909) (glutathione synthetase deficiency), [MONDO:0009259](http://purl.obolibrary.org/obo/MONDO_0009259) (gamma-glutamylcysteine synthetase deficiency), [MONDO:0009825](http://purl.obolibrary.org/obo/MONDO_0009825) (5-oxoprolinase deficiency (disease)), 

**Corr. equiv. classes:** [OMIM:230450](http://purl.obolibrary.org/obo/OMIM_230450), [OMIM:260005](http://purl.obolibrary.org/obo/OMIM_260005), [OMIM:266130](http://purl.obolibrary.org/obo/OMIM_266130), [Orphanet:289849](http://www.orpha.net/ORDO/Orphanet_289849), [OMIM:231950](http://purl.obolibrary.org/obo/OMIM_231950), [Orphanet:289846](http://www.orpha.net/ORDO/Orphanet_289846), [Orphanet:32](http://www.orpha.net/ORDO/Orphanet_32), [Orphanet:33573](http://www.orpha.net/ORDO/Orphanet_33573), [OMIM:231900](http://purl.obolibrary.org/obo/OMIM_231900), [Orphanet:33572](http://www.orpha.net/ORDO/Orphanet_33572), [Orphanet:33574](http://www.orpha.net/ORDO/Orphanet_33574), 

**Class expressions from DL-Learner:**

- [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 63.64%
- [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 63.64%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 63.64%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 63.64%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 63.64%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0003343](http://purl.obolibrary.org/obo/HP_0003343) (Glutathione synthetase deficiency) 63.64%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 33.17%
- Thing 33.16%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 33.16%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 29.63%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) 27.80%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 27.53%
- [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 27.02%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 27.02%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 25.65%


